United States · FDA National Drug Code directory
REBIF REBIDOSE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 44087-3322_037d2645-544b-41bb-bea8-00b578366ac6
- Product NDC
- 44087-3322
- Form
- INJECTION, SOLUTION
- Composition / generic term
- INTERFERON BETA-1A
- Labeler
- EMD Serono, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20121221
- Source listing expiry
- 20261231
Source-listed ingredients
- INTERFERON BETA-1A — 22 ug/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 12 PACKAGE in 1 CARTON (44087-3322-1) / .5 mL in 1 PACKAGE (44087-3322-9) · 44087-3322-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →